Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

This publication has 18 references indexed in Scilit:

• Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial
  JAMA, 1998
• A brief review for orthopedic surgeons: Fatigue damage (microdamage) in bone (its determinants and clinical implications)
  Journal of Orthopaedic Science, 1998
• Damage type and strain mode associations in human compact bone bending fatigue
  Journal of Orthopaedic Research, 1998
• Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial
  Archives of internal medicine (1960), 1997
• Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
  Journal of Clinical Investigation, 1997
• Bone Microdamage and Skeletal Fragility in Osteoporotic and Stress Fractures
  Journal of Bone and Mineral Research, 1997
• Bisphosphonates: Preclinical Aspects and Use in Osteoporosis
  Annals of Medicine, 1997
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
  The Lancet, 1996
• Risedronate treatment does not increase microdamage in the canine femoral neck
  Bone, 1995
• The long-term skeletal effects of EHDP in dogs
  Metabolic Bone Disease and Related Research, 1981